Back to results
US 8,263,652 B2Granted
Stabilized pediatric suspension of carisbamate
AssigneeSK Biopharmaceuticals Co., Ltd.
InventorsRoger Embrechts, Cedric De Leersnijder
Life of this patent
Estimating the term…
Abstract
The present invention provides a stabilized pharmaceutical suspension of carisbamate for pediatric and adult use. More particularly, the suspension is stabilized with hypromellose (HPMC) to prevent crystal growth of the suspended particles and to prevent re-crystallization of the drug product with change in polymorphic form.
Claims2
A pharmaceutical composition in the form of a stabilized aqueous suspension comprising:
- a) from about 10 to about 30 mg carisbamate;
- b) from about 5.0 to about 15.0 mg of hypromellose to stabilize the crystal structure and maintain polymorphic form of carisbamate;
- and
- c) about 1 ml. water.
1 more element
Dependencies are inferred from the claim text.